Larimar Therapeutics (LRMR) PT Lowered to $21 at Oppenheimer
Tweet
Share
E-mailGet Alerts LRMR Hot Sheet
Price: $3.94 --0%
Rating Summary:
12 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 30
Rating Summary:
12 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 30
Join SI Premium – FREE
Oppenheimer analyst Andreas Argyrides lowered the price target on Larimar Therapeutics (NASDAQ: LRMR) to $21.00 (from $26.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Nomura/Instinet Downgrades Internet Initiative Japan Inc (3774:JP) (IIJIY) to Neutral
- Nitto Denko (6988:JP) (NDEKY) PT Raised to JPY3,800 at Nomura/Instinet
- Nomura/Instinet Downgrades Petpal Pet Nutrition Technology (300673:CH) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
